Princeton Portfolio Strategies Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $8.22M | Buy |
105,720
+22,532
| +27% | +$1.68M | 1.59% | 25 |
|
|
2021
Q1 | $6.12M | Sell |
83,188
-623
| -0.7% | -$46K | 1.19% | 28 |
|
|
2020
Q4 | $6.54M | Sell |
83,811
-628
| -0.7% | -$48K | 1.29% | 27 |
|
|
2020
Q3 | $6.68M | Sell |
84,439
-2,568
| -3% | -$201K | 1.46% | 24 |
|
|
2020
Q2 | $6.42M | Sell |
87,007
-3,892
| -4% | -$293K | 1.53% | 23 |
|
|
2020
Q1 | $6.67M | Sell |
90,899
-864
| -0.9% | -$67.9K | 1.94% | 16 |
|
|
2019
Q4 | $7.96M | Sell |
91,763
-1,100
| -1% | -$90.3K | 1.88% | 19 |
|
|
2019
Q3 | $7.46M | Sell |
92,863
-1,101
| -1% | -$88.2K | 1.87% | 20 |
|
|
2019
Q2 | $7.52M | Sell |
93,964
-1,307
| -1% | -$100K | 1.91% | 17 |
|
|
2019
Q1 | $7.56M | Sell |
95,271
-530
| -0.6% | -$39.6K | 2.02% | 15 |
|
|
2018
Q4 | $6.99M | Sell |
95,801
-4,737
| -5% | -$334K | 2.18% | 12 |
|
|
2018
Q3 | $6.8M | Buy |
100,538
+1,487
| +2% | +$94.7K | 1.77% | 17 |
|
|
2018
Q2 | $5.74M | Sell |
99,051
-3,509
| -3% | -$198K | 1.66% | 17 |
|
|
2018
Q1 | $5.33M | Sell |
102,560
-5,027
| -5% | -$271K | 1.51% | 18 |
|
|
2017
Q4 | $5.78M | Sell |
107,587
-549
| -0.5% | -$30.4K | 1.58% | 16 |
|
|
2017
Q3 | $6.61M | Sell |
108,136
-279
| -0.3% | -$16.9K | 1.79% | 12 |
|
|
2017
Q2 | $6.63M | Buy |
108,415
+175
| +0.2% | +$10.7K | 1.9% | 12 |
|
|
2017
Q1 | $6.56M | Buy |
108,240
+994
| +0.9% | +$60.3K | 1.95% | 12 |
|
|
2016
Q4 | $6.02M | Sell |
107,246
-9,257
| -8% | -$542K | 1.9% | 11 |
|
|
2016
Q3 | $6.94M | Sell |
116,503
-1,380
| -1% | -$80.7K | 2.18% | 9 |
|
|
2016
Q2 | $6.48M | Buy |
117,883
+2,302
| +2% | +$123K | 2.09% | 9 |
|
|
2016
Q1 | $5.83M | Buy |
115,581
+3,666
| +3% | +$180K | 1.98% | 14 |
|
|
2015
Q4 | $5.64M | Buy |
111,915
+19,804
| +22% | +$998K | 2% | 14 |
|
|
2015
Q3 | $4.34M | Buy |
92,111
+2,961
| +3% | +$157K | 1.76% | 19 |
|
|
2015
Q2 | $4.84M | Buy |
89,150
+16,437
| +23% | +$922K | 1.7% | 18 |
|
|
2015
Q1 | $3.99M | Sell |
72,713
-15,673
| -18% | -$887K | 1.54% | 26 |
|
|
2014
Q4 | $4.79M | Buy |
88,386
+367
| +0.4% | +$20.4K | 1.9% | 12 |
|
|
2014
Q3 | $4.98M | Sell |
88,019
-3,040
| -3% | -$171K | 2.09% | 12 |
|
|
2014
Q2 | $5.03M | Buy |
91,059
+30,586
| +51% | +$1.67M | 2.15% | 11 |
|
|
2014
Q1 | $3.28M | Buy |
60,473
+18,665
| +45% | +$967K | 2.17% | 11 |
|
|
2013
Q4 | $2M | Buy |
41,808
+7,755
| +23% | +$354K | 1.34% | 22 |
|
|
2013
Q3 | $1.55M | Buy |
34,053
+3,485
| +11% | +$159K | 1.14% | 27 |
|
|
2013
Q2 | $1.35M | Buy |
+30,568
| New | +$1.37M | 1.11% | 28 |
|
Other funds holding MRK
Princeton Portfolio Strategies Group's MRK Position: Q2 2021 in Review
Princeton Portfolio Strategies Group increased its Merck (MRK) stake by 27% in Q2 2021, buying an estimated $1.68M and bringing the position to 105,720 shares worth $8.22M. The position accounts for 1.59% of the portfolio, ranked #25.
Princeton Portfolio Strategies Group first reported a position in MRK in Q2 2013 and has held it in 33 quarters since. 2,673 funds tracked by Wall St. Rank hold MRK as of Q2 2021.
- Princeton Portfolio Strategies Group held 105,720 shares of Merck worth $8.22M as of Q2 2021.
- Princeton Portfolio Strategies Group bought 22,532 Merck shares in Q2 2021, an estimated $1.68M.
- Merck made up 1.59% of Princeton Portfolio Strategies Group's portfolio in Q2 2021, its #25 holding.
- Princeton Portfolio Strategies Group first reported a position in Merck in Q2 2013 and has held it in 33 quarters since.
- 2,673 funds tracked by Wall St. Rank held Merck as of Q2 2021.
Based on Princeton Portfolio Strategies Group's 13F filing for Q2 2021, filed 2 Aug 2021.